Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Russell

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
Msphere|September 24, 2020
Nutrition and the Gut Microbiota in 10- to 18-Month-Old Children Living in Urban Slums of Mumbai, IndiaSamantha L Huey, Lingjing Jiang, Marcus W Fedarko, et al.
Journal of Medicinal Chemistry|May 26, 2023
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in MycobacteriaSatish R Malwal, Ben Mazurek, Jihee Ko, et al.
Elife|September 25, 2015
Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteriaRyan M McCormack, Lesley R de Armas, Motoaki Shiratsuchi, et al.
Wellcome Open Research|December 24, 2016
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayPaul Fineran, Emyr Lloyd-Evans, Nathan A Lack, et al.
Blood|May 21, 2013
Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutationsXi Wen Zhao, Roel P Gazendam, Agata Drewniak, et al.
JAMA Network Open|January 12, 2021
Parental Factors Associated With the Decision to Participate in a Neonatal Clinical TrialElliott Mark Weiss, Aleksandra E Olszewski, Katherine F Guttmann, et al.
The Journal of Pediatrics|August 17, 2021
Parental Enrollment Decision-Making for a Neonatal Clinical TrialElliott Mark Weiss, Katherine F Guttmann, Aleksandra E Olszewski, et al.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
Msphere|September 24, 2020
Nutrition and the Gut Microbiota in 10- to 18-Month-Old Children Living in Urban Slums of Mumbai, IndiaSamantha L Huey, Lingjing Jiang, Marcus W Fedarko, et al.
Journal of Medicinal Chemistry|May 26, 2023
Investigation into the Mechanism of Action of the Tuberculosis Drug Candidate SQ109 and Its Metabolites and Analogues in MycobacteriaSatish R Malwal, Ben Mazurek, Jihee Ko, et al.
Elife|September 25, 2015
Perforin-2 is essential for intracellular defense of parenchymal cells and phagocytes against pathogenic bacteriaRyan M McCormack, Lesley R de Armas, Motoaki Shiratsuchi, et al.
Wellcome Open Research|December 24, 2016
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathwayPaul Fineran, Emyr Lloyd-Evans, Nathan A Lack, et al.
Blood|May 21, 2013
Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutationsXi Wen Zhao, Roel P Gazendam, Agata Drewniak, et al.
JAMA Network Open|January 12, 2021
Parental Factors Associated With the Decision to Participate in a Neonatal Clinical TrialElliott Mark Weiss, Aleksandra E Olszewski, Katherine F Guttmann, et al.
The Journal of Pediatrics|August 17, 2021
Parental Enrollment Decision-Making for a Neonatal Clinical TrialElliott Mark Weiss, Katherine F Guttmann, Aleksandra E Olszewski, et al.
Nature Medicine|July 6, 2021
The Tuberculosis Drug Accelerator at year 10: what have we learned?Bree B Aldridge, David Barros-Aguirre, Clifton E Barry, et al.
Pageof 16